Locus Biosciences
Biotechnology, 523 Davis Dr Ste 350, Morrisville, North Carolina, 27560, United States, 51-200 Employees
Phone Number: 91********
Who is LOCUS BIOSCIENCES
Next generation CRISPR technology for programmed cell death. Focused on developing therapies for infectious disease and the microbiome. Locus Biosciences novel approach to precision antim...
Read More
-
Headquarters: 523 Davis Dr Ste 350, Morrisville, North Carolina, 27560, United States
-
Date Founded: 2015
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from LOCUS BIOSCIENCES
Locus Biosciences Org Chart and Mapping
Email
Phone
Similar Companies to Locus Biosciences
Beam Therapeutics
-
501-1000
-
$ 50 Million to 100 Million
Inceptor Bio
-
51-200
-
$ 1 Million to 5 Million
Life Edit Therapeutics
-
51-200
-
$ 10 Million to 25 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Locus Biosciences
Answer: Locus Biosciences's headquarters are located at 523 Davis Dr Ste 350, Morrisville, North Carolina, 27560, United States
Answer: Locus Biosciences's phone number is 91********
Answer: Locus Biosciences's official website is https://locus-bio.com
Answer: Locus Biosciences's revenue is $10 Million to $25 Million
Answer: Locus Biosciences's SIC: 8731
Answer: Locus Biosciences has 51-200 employees
Answer: Locus Biosciences is in Biotechnology
Answer: Locus Biosciences top competitors include: Beam Therapeutics , Inceptor Bio , Life Edit Therapeutics
Answer: Locus Biosciences contact info: Phone number: 91******** Website: https://locus-bio.com
Answer: Next generation CRISPR technology for programmed cell death. Focused on developing therapies for infectious disease and the microbiome. Locus Biosciences novel approach to precision antimicrobials works by taking advantage of a part of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating small strands of RNA called CRISPR RNAs, which match DNA sequences specific to a given invader. When the CRISPR RNAs find a match, they activate Cas proteins that cut the DNA. Locus Biosciences has developed a platform to design and deliver custom CRISPR-Cas systems directly to specific bacteria. Guided by the custom Locus Bio CRISPRs, the Type-I Cas proteins work to destroy bacterial DNA and cause the bacterial targets to self-destruct. Locus platform enables the development of antimicrobials which avoid currently known resistance mechanisms while leaving non-target bacteria unharmed. Built on prokaryotic technology for prokaryotic targets, Locus is advancing its platform to create therapeutics for critical-need therapeutic areas ranging from resistant bacterial infections to the microbiome.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month